Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > 9% in pre-market

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Aug 10, 2022 10:01am

107 Views

Post# 34884374

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:9% in pre-market

It looks like someone needed out in a bad way (trying to get in front of a margin call maybe?) and dumped the sizable amount of shares at the open. The market maker accomodated them by taking the stock off their hands at alow price and the stock has rebounded to more normal levels since the one rushed seller is out of the way now.

This is what happens when trading volume dries up. The good news is it can happen on the upside too.